Topic summary

Coverage for the indication versus for the drug — a second dataset

Access › Insurance & coverage prior authorisation appeals formulary insurance Solved Closed

This is a generated summary. It shows the 7 most-liked posts from a topic of 51, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.

KnowltonTL3Regular5 Mar 2025#3

e.ferrari, post #2: Clear enough that I do not think I have a follow-up, which is unusual. Go to post

I disagree with the framing of Coverage above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be checked.

The reasoning depends on an assumption that is doing a lot of work and is never stated. If the assumption holds, the conclusion follows. I do not think it holds generally.

32 likes in reply to #2 17mo

n.torrenceTL3Regular Solution8 Mar 2025#7

Picking up post #6: that is the part I would want checked first.

Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves frustration.

24 likes 17mo

mi.almeidaTL210 Mar 2025#10

Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift.

31 likes 17mo

e.lokkenTL213 Mar 2025#15

i.rasmussen, post #8: On post #4 — agreed on the reasoning, with one qualification. Two things can be true about Coverage at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is people defending the first against attacks on the second. Go to post

A note on scope: what I am saying about Coverage applies to the case in the first post and I would not extend it further without checking.

33 likes in reply to #8 17mo

e.piresTL219 Mar 2025 · edited#27

Where coverage was granted, saying what the successful submission contained is one of the more useful posts on the site.

29 likes 16mo

w.novakTL3Regular23 Mar 2025 · edited#37

taper_shift, post #1: On the subject in the title: Coverage for the indication versus for the drug — a second dataset Working notes rather than a conclusion. Posting a small dataset on Coverage. It is mine, it is uncontrolled, and the method is stated so it can be discounted appropriately. What I would like is not agreement but a second dataset collected by… Go to post

Where I have landed on Coverage, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has borrowed it from somewhere that did not measure it.

27 likes in reply to #1 16mo

d.barrosTL227 Mar 2025#46

a.kowalski, post #26: Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves surprise at the pharmacy. That has held every time I have looked, which is not the same as always. Go to post

Post #44 describes the usual case. This is about the unusual one.

Coverage looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.

33 likes in reply to #26 16mo

Read the full topic (51 posts)

This topic was referenced in

Appeal templates and why they are deliberately unemotional — one year onAccess › Insurance & coverage · 2 replies

This topic was closed 60 days after the last reply. Closing is automatic for quiet topics so that a settled answer does not collect new questions underneath it. If you have a follow-up, open a new topic and link back to this one — that keeps both readable and gives your question its own title.

Suggested topics

Topic	Participants	Replies	Views	Activity
External review after an internal denial Access › Insurance & coverage appeals prior authorisation insurance formulary Solved External review after an internal denial Writing it up because I had to work it out twice and would rather nobody else did. Proposing that external review deserves a maintained page rather than a recurring…		2	18k	1mo
Appeal templates and why they are deliberately unemotional — one year on Access › Insurance & coverage insurance appeals prior authorisation formulary Closed Appeal templates and why they are deliberately unemotional — one year on Writing it up because I had to work it out twice and would rather nobody else did. A narrow question about Appeal templates,…		2	4.1k	11mo
Documentation that materially improves an appeal's chances Access › Insurance & coverage insurance appeals formulary prior authorisation Documentation that materially improves an appeal's chances — setting out what I have, and where I think it stops being reliable. An honest uncertainty about documentation rather than a disguised assertion. I…	+93	98	3.6k	8mo
Step therapy requirements and how to satisfy them Access › Insurance & coverage prior authorisation insurance formulary Posting this under the heading it deserves: Step therapy requirements and how to satisfy them Everything below is what sits behind that. I would like to know what people here actually do about step therapy…	+21	25	49k	2mo
Prior authorisation: what the criteria usually require Access › Insurance & coverage prior authorisation formulary appeals insurance Solved On the subject in the title: Prior authorisation: what the criteria usually require Working notes rather than a conclusion. I would like to know what people here actually do about prior authorisation, as…	+9	13	3.2k	17mo

Related topics — sharing the tags prior authorisation, appeals, formulary

Topic	Participants	Replies	Views	Activity
What a good consultation looks like from the other side Clinical › Prescriber conversations prior authorisation telehealth type 2 diabetes beginner friendly What a good consultation looks like from the other side — that is the question, and I have not found it answered plainly anywhere I have looked. Something about good consultation does not reconcile and I…	+57	62	4.9k	22h
Follow-up: External review after an internal denial Access › Insurance & coverage prior authorisation formulary insurance Solved Posting this under the heading it deserves: External review after an internal denial Everything below is what sits behind that. Proposing that External review deserves a maintained page rather than a…	+6	10	12k	15h
Reading a denial letter as a specification for your appeal Access › Insurance & coverage appeals prior authorisation insurance Closed Reading a denial letter as a specification for your appeal Writing it up because I had to work it out twice and would rather nobody else did. Reading back through what has been written here about reading a…		3	30k	12mo
Asking about a compound your prescriber has not heard of — one year on Clinical › Prescriber conversations beginner friendly type 2 diabetes prior authorisation Solved Under review On the subject in the title: Asking about a compound your prescriber has not heard of — one year on Working notes rather than a conclusion. A question about how to describe something to a clinician rather…	+11	15	3.7k	19mo
List price versus negotiated price versus what you pay Access › Pricing formulary data table compounding Under review On the subject in the title: List price versus negotiated price versus what you pay Working notes rather than a conclusion. List price versus negotiated price — I have the observation and I do not trust my…	+99	115	11k	3mo